Sutro Biopharma STRO
NASDAQ STRO
$20.07 -0.47 (-2.29%)
As of: Sep 4, 2026 · 3:59 PM EDT

Sutro Biopharma (STRO) Assets (QoQ) (2018 - 2025)

Analysis

Sutro Biopharma (STRO) Assets (QoQ) (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Sutro Biopharma 334.33 Mn 169.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -17.09%
Sep 30, 2025 -20.09%
Jun 30, 2025 -18.38%
Mar 31, 2025 -16.99%
Dec 31, 2024 -14.30%
Sep 30, 2024 -7.61%
Jun 30, 2024 21.23%
Mar 31, 2024 -14.30%
Dec 31, 2023 9.03%
Sep 30, 2023 -7.13%
Jun 30, 2023 29.85%
Mar 31, 2023 -12.02%
Dec 31, 2022 1.56%
Sep 30, 2022 3.91%
Jun 30, 2022 26.98%
Mar 31, 2022 -11.05%
Dec 31, 2021 -8.09%
Sep 30, 2021 3.25%
Jun 30, 2021 0.35%
Mar 31, 2021 -9.03%